Flexion Therapeutics, Inc. (NASDAQ:FLXN) shares traded -1.73% during the most recent session. Wall Street analysts covering the stock are projecting that the stock will reach $35.86 within the next 52-weeks. Since analyst price targets calculations are subjective, there often can be a wide range of targets from various analysts. This is the consensus price target based on the analysts polled by Thomson Reuters’ First Call as of today’s date.
Sell-side analysts are able to use multiple metrics in order to help calculate target price estimates. A widely used metric is a company’s preice to earnings ratio. This calculation is derived from dividing the current share price by the projected earnings per share. Flexion Therapeutics, Inc. currently has a P/E Ratio of N/A. Investors might also evaluate a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. If a company has a PEG Ratio under one, it may be seen as undervalued. If a company has a PEG Ratio over one, it may represent that the company is overvalued. A PEG Ratio near one may be viewed as fair value. Currently, the company has a PEG Ratio of 0.00.
Looking at stock performance, company shares have recently traded $-1.14 away from the 50-day moving average of $19.34 and $1.62 away from the 200-day moving average of $16.58. The stock has been recently noted -22.78% off of the 52-week high of 23.57 and +140.74% off of the 52-week low of 7.56. Monitoring the stock price relative to moving averages and highs and lows for the year may help evaluate the value of the stock in the future.